Subscribe to our press releases
ChromoGenics makes changes to the management team
The company has made progress with reducing costs and improving efficiencies and will now accelerate that work. Victor Hägglund is appointed COO and assumes the overall responsibility for purchasing, production, and supply chain. Victor will in his new role drive and quantify cost reductions and efficiency improvements.
Sales, partner development and international expansion are of strategic importance for the company. Therefore, Fredrik Fränding, CEO, assumes the role of interim Head of Sales. Linus Wetterlind will leave the company end of September.
“Order intake in the second quarter was better compared to recent quarters but we see a challenging period in front of us, affected by rising interest rates and an uncertain global environment. Growing our business together with partners is therefore an even more important part of our strategy, which involves the whole company. I want to thank Linus for his contributions and wish him all the best going forward”. Says Fredrik Fränding, CEO.
This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.
ChromoGenics is a PropTech company that produces dynamic glass for real estate. One company product, ConverLight® Dynamic, controls indoor comfort by optimising daylighting, good views and blocking solar heat, and thereby contributing to reducing costs for cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are sputtered onto plastic film and then laminated between glass layers. The plastic film is easy to transport which means long distance shipping of bulky glass can be avoided. ChromoGenics also offers ConverLight® Static, a static glass version, and a façade glazing solution, ConverLight® Energy. ChromoGenics has supplied glazing technology to a large number of major real estate companies. Its shares were listed on the Nasdaq First North Growth Market in 2017.
ChromoGenics emerged from world-leading research at the Ångström Laboratory at Uppsala University. The company’s production site in Uppsala has been partly financed via conditional loans from the Swedish Energy Agency. ChromoGenics shares (CHRO) are listed on the Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: email@example.com, +46 (0)8 463 83 00.